Pepgen Inc
Clinical trials sponsored by Pepgen Inc, explained in plain language.
-
New drug trial targets muscle disease
Disease control Recruiting nowThis study is testing an investigational drug called PGN-EDODM1 in adults with myotonic dystrophy type 1, a genetic muscle disorder. Researchers want to see if multiple doses are safe and tolerable compared to a placebo. They will also measure how the drug affects muscle stiffnes…
Phase: PHASE2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Hope for muscle disease: Long-Term drug safety study opens
Disease control Recruiting nowThis study aims to learn about the long-term safety of an experimental drug called PGN-EDODM1 for adults with myotonic dystrophy type 1. It is open only to people who have already received this drug in a previous clinical trial. The main goal is to monitor participants for any si…
Phase: PHASE2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC